What is the risk of bowel perforation associated with bevacizumab therapy in ovarian cancer?
Year: 2007
Type: editorial
Source: Gynecologic Oncology
Authors: E HAN, B MONK
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1973183162
